nodes	percent_of_prediction	percent_of_DWPC	metapath
Orphenadrine—SCN9A—epilepsy syndrome	0.0926	0.341	CbGaD
Orphenadrine—SCN4A—epilepsy syndrome	0.0851	0.313	CbGaD
Orphenadrine—SCN1A—epilepsy syndrome	0.0622	0.229	CbGaD
Orphenadrine—CHRM2—epilepsy syndrome	0.0316	0.117	CbGaD
Orphenadrine—GRIN3A—Felbamate—epilepsy syndrome	0.0205	0.0587	CbGbCtD
Orphenadrine—Warfarin—Phenytoin—epilepsy syndrome	0.0156	0.0678	CrCrCtD
Orphenadrine—SCN9A—Lacosamide—epilepsy syndrome	0.0145	0.0417	CbGbCtD
Orphenadrine—SCN9A—Lamotrigine—epilepsy syndrome	0.0145	0.0417	CbGbCtD
Orphenadrine—Warfarin—Oxcarbazepine—epilepsy syndrome	0.0132	0.0576	CrCrCtD
Orphenadrine—Phenprocoumon—Phenytoin—epilepsy syndrome	0.0132	0.0573	CrCrCtD
Orphenadrine—SCN9A—Rufinamide—epilepsy syndrome	0.0128	0.0368	CbGbCtD
Orphenadrine—Modafinil—Fosphenytoin—epilepsy syndrome	0.0128	0.0555	CrCrCtD
Orphenadrine—SCN9A—Carbamazepine—epilepsy syndrome	0.0125	0.0359	CbGbCtD
Orphenadrine—SCN4A—Lamotrigine—epilepsy syndrome	0.0123	0.0352	CbGbCtD
Orphenadrine—SCN10A—Lamotrigine—epilepsy syndrome	0.0114	0.0327	CbGbCtD
Orphenadrine—SCN1A—Lamotrigine—epilepsy syndrome	0.0114	0.0327	CbGbCtD
Orphenadrine—SCN10A—Lacosamide—epilepsy syndrome	0.0114	0.0327	CbGbCtD
Orphenadrine—SCN9A—Phenytoin—epilepsy syndrome	0.0112	0.0322	CbGbCtD
Orphenadrine—SCN4A—Rufinamide—epilepsy syndrome	0.0108	0.0311	CbGbCtD
Orphenadrine—SCN5A—Oxcarbazepine—epilepsy syndrome	0.0107	0.0306	CbGbCtD
Orphenadrine—SCN4A—Carbamazepine—epilepsy syndrome	0.0106	0.0303	CbGbCtD
Orphenadrine—SCN1A—Rufinamide—epilepsy syndrome	0.0101	0.0289	CbGbCtD
Orphenadrine—SCN10A—Rufinamide—epilepsy syndrome	0.0101	0.0289	CbGbCtD
Orphenadrine—Cyclobenzaprine—Carbamazepine—epilepsy syndrome	0.00993	0.0432	CrCrCtD
Orphenadrine—Doxepin—Oxcarbazepine—epilepsy syndrome	0.00973	0.0423	CrCrCtD
Orphenadrine—SCN4A—Phenytoin—epilepsy syndrome	0.00948	0.0272	CbGbCtD
Orphenadrine—SCN5A—Fosphenytoin—epilepsy syndrome	0.00935	0.0268	CbGbCtD
Orphenadrine—SCN9A—Zonisamide—epilepsy syndrome	0.00926	0.0265	CbGbCtD
Orphenadrine—Benzyl Benzoate—Fosphenytoin—epilepsy syndrome	0.00888	0.0387	CrCrCtD
Orphenadrine—SCN4A—Propofol—epilepsy syndrome	0.00884	0.0253	CbGbCtD
Orphenadrine—SCN1A—Phenytoin—epilepsy syndrome	0.00882	0.0253	CbGbCtD
Orphenadrine—Modafinil—Phenytoin—epilepsy syndrome	0.00874	0.038	CrCrCtD
Orphenadrine—Ethopropazine—Carbamazepine—epilepsy syndrome	0.00825	0.0359	CrCrCtD
Orphenadrine—Amitriptyline—Oxcarbazepine—epilepsy syndrome	0.00819	0.0356	CrCrCtD
Orphenadrine—Trimipramine—Carbamazepine—epilepsy syndrome	0.00807	0.0351	CrCrCtD
Orphenadrine—Modafinil—Carbamazepine—epilepsy syndrome	0.00807	0.0351	CrCrCtD
Orphenadrine—SCN4A—Zonisamide—epilepsy syndrome	0.00782	0.0224	CbGbCtD
Orphenadrine—SCN5A—Lamotrigine—epilepsy syndrome	0.00781	0.0224	CbGbCtD
Orphenadrine—Dimetacrine—Carbamazepine—epilepsy syndrome	0.00771	0.0336	CrCrCtD
Orphenadrine—Trimipramine—Oxcarbazepine—epilepsy syndrome	0.00743	0.0323	CrCrCtD
Orphenadrine—Modafinil—Oxcarbazepine—epilepsy syndrome	0.00743	0.0323	CrCrCtD
Orphenadrine—Imipramine—Carbamazepine—epilepsy syndrome	0.0074	0.0322	CrCrCtD
Orphenadrine—SCN1A—Zonisamide—epilepsy syndrome	0.00727	0.0208	CbGbCtD
Orphenadrine—Dimetacrine—Oxcarbazepine—epilepsy syndrome	0.00711	0.0309	CrCrCtD
Orphenadrine—SCN5A—Rufinamide—epilepsy syndrome	0.0069	0.0197	CbGbCtD
Orphenadrine—Promethazine—Carbamazepine—epilepsy syndrome	0.00684	0.0298	CrCrCtD
Orphenadrine—Imipramine—Oxcarbazepine—epilepsy syndrome	0.00681	0.0297	CrCrCtD
Orphenadrine—SCN5A—Carbamazepine—epilepsy syndrome	0.00672	0.0192	CbGbCtD
Orphenadrine—Alimemazine—Carbamazepine—epilepsy syndrome	0.00672	0.0292	CrCrCtD
Orphenadrine—Benzphetamine—Phenytoin—epilepsy syndrome	0.00657	0.0286	CrCrCtD
Orphenadrine—Promethazine—Oxcarbazepine—epilepsy syndrome	0.0063	0.0274	CrCrCtD
Orphenadrine—Alimemazine—Oxcarbazepine—epilepsy syndrome	0.00619	0.0269	CrCrCtD
Orphenadrine—Benzyl Benzoate—Phenytoin—epilepsy syndrome	0.00609	0.0265	CrCrCtD
Orphenadrine—SCN5A—Phenytoin—epilepsy syndrome	0.00603	0.0173	CbGbCtD
Orphenadrine—Diphenhydramine—Phenytoin—epilepsy syndrome	0.00583	0.0254	CrCrCtD
Orphenadrine—Promazine—Carbamazepine—epilepsy syndrome	0.00579	0.0252	CrCrCtD
Orphenadrine—Benzyl Benzoate—Carbamazepine—epilepsy syndrome	0.00562	0.0245	CrCrCtD
Orphenadrine—Promazine—Oxcarbazepine—epilepsy syndrome	0.00533	0.0232	CrCrCtD
Orphenadrine—SCN1A—Topiramate—epilepsy syndrome	0.0053	0.0152	CbGbCtD
Orphenadrine—SCN5A—Zonisamide—epilepsy syndrome	0.00497	0.0142	CbGbCtD
Orphenadrine—CYP2E1—Felbamate—epilepsy syndrome	0.00399	0.0114	CbGbCtD
Orphenadrine—CYP2E1—Trimethadione—epilepsy syndrome	0.00399	0.0114	CbGbCtD
Orphenadrine—CYP2B6—Fosphenytoin—epilepsy syndrome	0.0037	0.0106	CbGbCtD
Orphenadrine—SCN5A—Topiramate—epilepsy syndrome	0.00362	0.0104	CbGbCtD
Orphenadrine—CYP2E1—Clonazepam—epilepsy syndrome	0.00339	0.00971	CbGbCtD
Orphenadrine—CYP2B6—Clobazam—epilepsy syndrome	0.00321	0.00918	CbGbCtD
Orphenadrine—CYP2E1—Rufinamide—epilepsy syndrome	0.00276	0.00792	CbGbCtD
Orphenadrine—CYP2B6—Carbamazepine—epilepsy syndrome	0.00266	0.00761	CbGbCtD
Orphenadrine—CYP2B6—Primidone—epilepsy syndrome	0.00248	0.0071	CbGbCtD
Orphenadrine—CYP2B6—Phenytoin—epilepsy syndrome	0.00238	0.00683	CbGbCtD
Orphenadrine—CYP2E1—Propofol—epilepsy syndrome	0.00225	0.00645	CbGbCtD
Orphenadrine—CYP2B6—Propofol—epilepsy syndrome	0.00222	0.00637	CbGbCtD
Orphenadrine—CYP2E1—Phenobarbital—epilepsy syndrome	0.00215	0.00617	CbGbCtD
Orphenadrine—CYP2B6—Phenobarbital—epilepsy syndrome	0.00212	0.00608	CbGbCtD
Orphenadrine—CYP2E1—Midazolam—epilepsy syndrome	0.00212	0.00608	CbGbCtD
Orphenadrine—CYP2B6—Midazolam—epilepsy syndrome	0.00209	0.006	CbGbCtD
Orphenadrine—CYP2E1—Diazepam—epilepsy syndrome	0.00204	0.00585	CbGbCtD
Orphenadrine—CYP2B6—Diazepam—epilepsy syndrome	0.00201	0.00577	CbGbCtD
Orphenadrine—GRIN1—telencephalic ventricle—epilepsy syndrome	0.00184	0.0662	CbGeAlD
Orphenadrine—CYP2B6—Valproic Acid—epilepsy syndrome	0.00159	0.00455	CbGbCtD
Orphenadrine—SLC6A2—locus ceruleus—epilepsy syndrome	0.00144	0.0518	CbGeAlD
Orphenadrine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0013	0.00372	CbGbCtD
Orphenadrine—CYP3A4—Felbamate—epilepsy syndrome	0.00121	0.00346	CbGbCtD
Orphenadrine—CYP3A4—Trimethadione—epilepsy syndrome	0.00121	0.00346	CbGbCtD
Orphenadrine—GRIN1—ganglion—epilepsy syndrome	0.00115	0.0412	CbGeAlD
Orphenadrine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00114	0.00325	CbGbCtD
Orphenadrine—CYP3A4—Clonazepam—epilepsy syndrome	0.00103	0.00294	CbGbCtD
Orphenadrine—CYP3A4—Clobazam—epilepsy syndrome	0.000985	0.00282	CbGbCtD
Orphenadrine—GRIN2D—hindbrain—epilepsy syndrome	0.000975	0.0351	CbGeAlD
Orphenadrine—GRIN1—hindbrain—epilepsy syndrome	0.000869	0.0312	CbGeAlD
Orphenadrine—CYP3A4—Rufinamide—epilepsy syndrome	0.000838	0.0024	CbGbCtD
Orphenadrine—CYP3A4—Carbamazepine—epilepsy syndrome	0.000816	0.00234	CbGbCtD
Orphenadrine—SLC6A2—autonomic nervous system—epilepsy syndrome	0.000765	0.0275	CbGeAlD
Orphenadrine—CYP3A4—Primidone—epilepsy syndrome	0.000762	0.00218	CbGbCtD
Orphenadrine—CYP3A4—Phenytoin—epilepsy syndrome	0.000732	0.0021	CbGbCtD
Orphenadrine—SCN10A—ganglion—epilepsy syndrome	0.000683	0.0246	CbGeAlD
Orphenadrine—CYP3A4—Propofol—epilepsy syndrome	0.000683	0.00196	CbGbCtD
Orphenadrine—CYP3A4—Acetazolamide—epilepsy syndrome	0.000653	0.00187	CbGbCtD
Orphenadrine—CYP3A4—Phenobarbital—epilepsy syndrome	0.000653	0.00187	CbGbCtD
Orphenadrine—CYP3A4—Midazolam—epilepsy syndrome	0.000643	0.00184	CbGbCtD
Orphenadrine—CYP3A4—Diazepam—epilepsy syndrome	0.000619	0.00177	CbGbCtD
Orphenadrine—CYP3A4—Zonisamide—epilepsy syndrome	0.000604	0.00173	CbGbCtD
Orphenadrine—SCN1A—hindbrain—epilepsy syndrome	0.000585	0.0211	CbGeAlD
Orphenadrine—GRIN2D—brainstem—epilepsy syndrome	0.000559	0.0201	CbGeAlD
Orphenadrine—GRIN2D—forebrain—epilepsy syndrome	0.000539	0.0194	CbGeAlD
Orphenadrine—GRIN3A—forebrain—epilepsy syndrome	0.000507	0.0182	CbGeAlD
Orphenadrine—GRIN1—brainstem—epilepsy syndrome	0.000498	0.0179	CbGeAlD
Orphenadrine—GRIN2D—telencephalon—epilepsy syndrome	0.000496	0.0178	CbGeAlD
Orphenadrine—CYP3A4—Valproic Acid—epilepsy syndrome	0.000488	0.0014	CbGbCtD
Orphenadrine—GRIN1—forebrain—epilepsy syndrome	0.000481	0.0173	CbGeAlD
Orphenadrine—GRIN3A—telencephalon—epilepsy syndrome	0.000466	0.0168	CbGeAlD
Orphenadrine—GRIN1—telencephalon—epilepsy syndrome	0.000442	0.0159	CbGeAlD
Orphenadrine—CYP3A4—Topiramate—epilepsy syndrome	0.00044	0.00126	CbGbCtD
Orphenadrine—SLC6A2—ganglion—epilepsy syndrome	0.000425	0.0153	CbGeAlD
Orphenadrine—GRIN2D—medulla oblongata—epilepsy syndrome	0.00039	0.014	CbGeAlD
Orphenadrine—GRIN2D—spinal cord—epilepsy syndrome	0.000347	0.0125	CbGeAlD
Orphenadrine—SCN1A—brainstem—epilepsy syndrome	0.000335	0.0121	CbGeAlD
Orphenadrine—SCN1A—forebrain—epilepsy syndrome	0.000324	0.0116	CbGeAlD
Orphenadrine—GRIN1—midbrain—epilepsy syndrome	0.000317	0.0114	CbGeAlD
Orphenadrine—GRIN1—spinal cord—epilepsy syndrome	0.00031	0.0111	CbGeAlD
Orphenadrine—GRIN2D—head—epilepsy syndrome	0.000309	0.0111	CbGeAlD
Orphenadrine—SCN1A—telencephalon—epilepsy syndrome	0.000298	0.0107	CbGeAlD
Orphenadrine—GRIN2D—nervous system—epilepsy syndrome	0.000293	0.0105	CbGeAlD
Orphenadrine—GRIN3A—head—epilepsy syndrome	0.00029	0.0104	CbGeAlD
Orphenadrine—SCN10A—forebrain—epilepsy syndrome	0.000287	0.0103	CbGeAlD
Orphenadrine—GRIN2D—central nervous system—epilepsy syndrome	0.000282	0.0101	CbGeAlD
Orphenadrine—GRIN2D—cerebellum—epilepsy syndrome	0.000275	0.00991	CbGeAlD
Orphenadrine—GRIN3A—nervous system—epilepsy syndrome	0.000275	0.0099	CbGeAlD
Orphenadrine—GRIN1—head—epilepsy syndrome	0.000275	0.0099	CbGeAlD
Orphenadrine—GRIN3A—central nervous system—epilepsy syndrome	0.000265	0.00953	CbGeAlD
Orphenadrine—SCN10A—telencephalon—epilepsy syndrome	0.000264	0.00948	CbGeAlD
Orphenadrine—GRIN1—nervous system—epilepsy syndrome	0.000261	0.00938	CbGeAlD
Orphenadrine—GRIN1—central nervous system—epilepsy syndrome	0.000251	0.00903	CbGeAlD
Orphenadrine—SCN9A—midbrain—epilepsy syndrome	0.000249	0.00894	CbGeAlD
Orphenadrine—GRIN1—cerebellum—epilepsy syndrome	0.000245	0.00883	CbGeAlD
Orphenadrine—SCN9A—spinal cord—epilepsy syndrome	0.000243	0.00872	CbGeAlD
Orphenadrine—SCN1A—medulla oblongata—epilepsy syndrome	0.000234	0.00841	CbGeAlD
Orphenadrine—GRIN2D—brain—epilepsy syndrome	0.000224	0.00805	CbGeAlD
Orphenadrine—CHRM2—forebrain—epilepsy syndrome	0.000222	0.00797	CbGeAlD
Orphenadrine—SCN1A—midbrain—epilepsy syndrome	0.000214	0.00769	CbGeAlD
Orphenadrine—GRIN3A—brain—epilepsy syndrome	0.00021	0.00757	CbGeAlD
Orphenadrine—SCN1A—spinal cord—epilepsy syndrome	0.000209	0.0075	CbGeAlD
Orphenadrine—CHRM2—telencephalon—epilepsy syndrome	0.000204	0.00733	CbGeAlD
Orphenadrine—GRIN1—brain—epilepsy syndrome	0.000199	0.00717	CbGeAlD
Orphenadrine—SCN4A—head—epilepsy syndrome	0.000192	0.00692	CbGeAlD
Orphenadrine—SCN1A—head—epilepsy syndrome	0.000185	0.00667	CbGeAlD
Orphenadrine—SLC6A2—brainstem—epilepsy syndrome	0.000185	0.00665	CbGeAlD
Orphenadrine—SCN10A—spinal cord—epilepsy syndrome	0.000185	0.00664	CbGeAlD
Orphenadrine—SCN4A—nervous system—epilepsy syndrome	0.000182	0.00656	CbGeAlD
Orphenadrine—SLC6A2—forebrain—epilepsy syndrome	0.000178	0.00641	CbGeAlD
Orphenadrine—SCN1A—nervous system—epilepsy syndrome	0.000176	0.00632	CbGeAlD
Orphenadrine—SCN4A—central nervous system—epilepsy syndrome	0.000176	0.00631	CbGeAlD
Orphenadrine—SCN1A—central nervous system—epilepsy syndrome	0.000169	0.00609	CbGeAlD
Orphenadrine—SCN1A—cerebellum—epilepsy syndrome	0.000165	0.00595	CbGeAlD
Orphenadrine—SCN10A—head—epilepsy syndrome	0.000164	0.0059	CbGeAlD
Orphenadrine—SLC6A2—telencephalon—epilepsy syndrome	0.000164	0.0059	CbGeAlD
Orphenadrine—KCNH2—forebrain—epilepsy syndrome	0.00016	0.00576	CbGeAlD
Orphenadrine—SCN9A—brain—epilepsy syndrome	0.000156	0.00562	CbGeAlD
Orphenadrine—SCN10A—nervous system—epilepsy syndrome	0.000156	0.0056	CbGeAlD
Orphenadrine—SCN10A—central nervous system—epilepsy syndrome	0.00015	0.00539	CbGeAlD
Orphenadrine—SCN5A—head—epilepsy syndrome	0.000149	0.00536	CbGeAlD
Orphenadrine—KCNH2—telencephalon—epilepsy syndrome	0.000147	0.0053	CbGeAlD
Orphenadrine—SCN5A—nervous system—epilepsy syndrome	0.000141	0.00509	CbGeAlD
Orphenadrine—SCN4A—brain—epilepsy syndrome	0.000139	0.00501	CbGeAlD
Orphenadrine—SCN5A—central nervous system—epilepsy syndrome	0.000136	0.0049	CbGeAlD
Orphenadrine—SCN1A—brain—epilepsy syndrome	0.000134	0.00483	CbGeAlD
Orphenadrine—SLC6A2—medulla oblongata—epilepsy syndrome	0.000129	0.00463	CbGeAlD
Orphenadrine—HRH1—forebrain—epilepsy syndrome	0.000128	0.00462	CbGeAlD
Orphenadrine—CHRM2—head—epilepsy syndrome	0.000127	0.00457	CbGeAlD
Orphenadrine—CHRM2—nervous system—epilepsy syndrome	0.00012	0.00433	CbGeAlD
Orphenadrine—SCN10A—brain—epilepsy syndrome	0.000119	0.00428	CbGeAlD
Orphenadrine—HRH1—telencephalon—epilepsy syndrome	0.000118	0.00424	CbGeAlD
Orphenadrine—CHRM2—central nervous system—epilepsy syndrome	0.000116	0.00417	CbGeAlD
Orphenadrine—KCNH2—medulla oblongata—epilepsy syndrome	0.000116	0.00416	CbGeAlD
Orphenadrine—CYP2E1—telencephalon—epilepsy syndrome	0.000113	0.00408	CbGeAlD
Orphenadrine—Constipation—Levetiracetam—epilepsy syndrome	0.000111	0.00198	CcSEcCtD
Orphenadrine—Feeling abnormal—Propofol—epilepsy syndrome	0.00011	0.00198	CcSEcCtD
Orphenadrine—Confusional state—Clonazepam—epilepsy syndrome	0.00011	0.00198	CcSEcCtD
Orphenadrine—Skin disorder—Zonisamide—epilepsy syndrome	0.00011	0.00198	CcSEcCtD
Orphenadrine—Dizziness—Lacosamide—epilepsy syndrome	0.00011	0.00198	CcSEcCtD
Orphenadrine—Confusional state—Phenytoin—epilepsy syndrome	0.00011	0.00196	CcSEcCtD
Orphenadrine—Anaphylactic shock—Clonazepam—epilepsy syndrome	0.00011	0.00196	CcSEcCtD
Orphenadrine—Confusional state—Oxcarbazepine—epilepsy syndrome	0.000109	0.00195	CcSEcCtD
Orphenadrine—Anaphylactic shock—Phenytoin—epilepsy syndrome	0.000109	0.00195	CcSEcCtD
Orphenadrine—Palpitations—Lamotrigine—epilepsy syndrome	0.000109	0.00195	CcSEcCtD
Orphenadrine—Somnolence—Vigabatrin—epilepsy syndrome	0.000108	0.00194	CcSEcCtD
Orphenadrine—Anaphylactic shock—Oxcarbazepine—epilepsy syndrome	0.000108	0.00194	CcSEcCtD
Orphenadrine—SCN5A—brain—epilepsy syndrome	0.000108	0.00389	CbGeAlD
Orphenadrine—Feeling abnormal—Midazolam—epilepsy syndrome	0.000108	0.00194	CcSEcCtD
Orphenadrine—Nausea—Phenobarbital—epilepsy syndrome	0.000108	0.00193	CcSEcCtD
Orphenadrine—Dizziness—Clobazam—epilepsy syndrome	0.000107	0.00192	CcSEcCtD
Orphenadrine—Tachycardia—Clonazepam—epilepsy syndrome	0.000107	0.00191	CcSEcCtD
Orphenadrine—Constipation—Fosphenytoin—epilepsy syndrome	0.000107	0.00191	CcSEcCtD
Orphenadrine—Feeling abnormal—Levetiracetam—epilepsy syndrome	0.000107	0.00191	CcSEcCtD
Orphenadrine—Somnolence—Diazepam—epilepsy syndrome	0.000107	0.00191	CcSEcCtD
Orphenadrine—Urticaria—Propofol—epilepsy syndrome	0.000106	0.00191	CcSEcCtD
Orphenadrine—Skin disorder—Clonazepam—epilepsy syndrome	0.000106	0.00191	CcSEcCtD
Orphenadrine—Tachycardia—Phenytoin—epilepsy syndrome	0.000106	0.0019	CcSEcCtD
Orphenadrine—Vomiting—Lacosamide—epilepsy syndrome	0.000106	0.0019	CcSEcCtD
Orphenadrine—KCNH2—midbrain—epilepsy syndrome	0.000106	0.0038	CbGeAlD
Orphenadrine—Tachycardia—Oxcarbazepine—epilepsy syndrome	0.000106	0.00189	CcSEcCtD
Orphenadrine—Nausea—Rufinamide—epilepsy syndrome	0.000106	0.00189	CcSEcCtD
Orphenadrine—Skin disorder—Oxcarbazepine—epilepsy syndrome	0.000105	0.00188	CcSEcCtD
Orphenadrine—Confusional state—Carbamazepine—epilepsy syndrome	0.000105	0.00188	CcSEcCtD
Orphenadrine—Headache—Lacosamide—epilepsy syndrome	0.000105	0.00187	CcSEcCtD
Orphenadrine—Constipation—Vigabatrin—epilepsy syndrome	0.000104	0.00187	CcSEcCtD
Orphenadrine—Urticaria—Midazolam—epilepsy syndrome	0.000104	0.00187	CcSEcCtD
Orphenadrine—Anaphylactic shock—Carbamazepine—epilepsy syndrome	0.000104	0.00186	CcSEcCtD
Orphenadrine—Drowsiness—Gabapentin—epilepsy syndrome	0.000104	0.00186	CcSEcCtD
Orphenadrine—Asthenia—Acetazolamide—epilepsy syndrome	0.000104	0.00185	CcSEcCtD
Orphenadrine—Somnolence—Felbamate—epilepsy syndrome	0.000103	0.00185	CcSEcCtD
Orphenadrine—KCNH2—spinal cord—epilepsy syndrome	0.000103	0.00371	CbGeAlD
Orphenadrine—Feeling abnormal—Fosphenytoin—epilepsy syndrome	0.000103	0.00184	CcSEcCtD
Orphenadrine—Vomiting—Clobazam—epilepsy syndrome	0.000103	0.00184	CcSEcCtD
Orphenadrine—Constipation—Diazepam—epilepsy syndrome	0.000103	0.00184	CcSEcCtD
Orphenadrine—SLC6A2—head—epilepsy syndrome	0.000102	0.00367	CbGeAlD
Orphenadrine—Headache—Clobazam—epilepsy syndrome	0.000101	0.00182	CcSEcCtD
Orphenadrine—Tachycardia—Carbamazepine—epilepsy syndrome	0.000101	0.00181	CcSEcCtD
Orphenadrine—Confusional state—Lamotrigine—epilepsy syndrome	0.000101	0.00181	CcSEcCtD
Orphenadrine—Somnolence—Zonisamide—epilepsy syndrome	0.000101	0.00181	CcSEcCtD
Orphenadrine—Hallucination—Pregabalin—epilepsy syndrome	0.000101	0.00181	CcSEcCtD
Orphenadrine—Skin disorder—Carbamazepine—epilepsy syndrome	0.000101	0.00181	CcSEcCtD
Orphenadrine—Feeling abnormal—Vigabatrin—epilepsy syndrome	0.0001	0.0018	CcSEcCtD
Orphenadrine—Urticaria—Fosphenytoin—epilepsy syndrome	9.93e-05	0.00178	CcSEcCtD
Orphenadrine—Constipation—Felbamate—epilepsy syndrome	9.93e-05	0.00178	CcSEcCtD
Orphenadrine—Nausea—Lacosamide—epilepsy syndrome	9.91e-05	0.00177	CcSEcCtD
Orphenadrine—Feeling abnormal—Diazepam—epilepsy syndrome	9.88e-05	0.00177	CcSEcCtD
Orphenadrine—Tachycardia—Lamotrigine—epilepsy syndrome	9.79e-05	0.00175	CcSEcCtD
Orphenadrine—Somnolence—Clonazepam—epilepsy syndrome	9.74e-05	0.00174	CcSEcCtD
Orphenadrine—Constipation—Zonisamide—epilepsy syndrome	9.72e-05	0.00174	CcSEcCtD
Orphenadrine—SLC6A2—nervous system—epilepsy syndrome	9.68e-05	0.00348	CbGeAlD
Orphenadrine—Urticaria—Vigabatrin—epilepsy syndrome	9.68e-05	0.00173	CcSEcCtD
Orphenadrine—Somnolence—Phenytoin—epilepsy syndrome	9.67e-05	0.00173	CcSEcCtD
Orphenadrine—Hypersensitivity—Midazolam—epilepsy syndrome	9.66e-05	0.00173	CcSEcCtD
Orphenadrine—Somnolence—Oxcarbazepine—epilepsy syndrome	9.62e-05	0.00172	CcSEcCtD
Orphenadrine—Nausea—Clobazam—epilepsy syndrome	9.62e-05	0.00172	CcSEcCtD
Orphenadrine—Asthenia—Propofol—epilepsy syndrome	9.62e-05	0.00172	CcSEcCtD
Orphenadrine—Tension—Valproic Acid—epilepsy syndrome	9.59e-05	0.00172	CcSEcCtD
Orphenadrine—Feeling abnormal—Felbamate—epilepsy syndrome	9.57e-05	0.00171	CcSEcCtD
Orphenadrine—Dizziness—Acetazolamide—epilepsy syndrome	9.54e-05	0.00171	CcSEcCtD
Orphenadrine—Hypersensitivity—Levetiracetam—epilepsy syndrome	9.54e-05	0.00171	CcSEcCtD
Orphenadrine—Urticaria—Diazepam—epilepsy syndrome	9.53e-05	0.00171	CcSEcCtD
Orphenadrine—Pruritus—Propofol—epilepsy syndrome	9.48e-05	0.0017	CcSEcCtD
Orphenadrine—Asthenia—Midazolam—epilepsy syndrome	9.41e-05	0.00169	CcSEcCtD
Orphenadrine—Constipation—Clonazepam—epilepsy syndrome	9.36e-05	0.00168	CcSEcCtD
Orphenadrine—Feeling abnormal—Zonisamide—epilepsy syndrome	9.36e-05	0.00168	CcSEcCtD
Orphenadrine—SLC6A2—central nervous system—epilepsy syndrome	9.32e-05	0.00335	CbGeAlD
Orphenadrine—Constipation—Phenytoin—epilepsy syndrome	9.3e-05	0.00167	CcSEcCtD
Orphenadrine—Asthenia—Levetiracetam—epilepsy syndrome	9.29e-05	0.00166	CcSEcCtD
Orphenadrine—Pruritus—Midazolam—epilepsy syndrome	9.28e-05	0.00166	CcSEcCtD
Orphenadrine—Hallucination—Gabapentin—epilepsy syndrome	9.26e-05	0.00166	CcSEcCtD
Orphenadrine—Constipation—Oxcarbazepine—epilepsy syndrome	9.25e-05	0.00166	CcSEcCtD
Orphenadrine—Somnolence—Carbamazepine—epilepsy syndrome	9.23e-05	0.00165	CcSEcCtD
Orphenadrine—Urticaria—Felbamate—epilepsy syndrome	9.22e-05	0.00165	CcSEcCtD
Orphenadrine—Vision blurred—Valproic Acid—epilepsy syndrome	9.21e-05	0.00165	CcSEcCtD
Orphenadrine—CHRM2—brain—epilepsy syndrome	9.2e-05	0.00331	CbGeAlD
Orphenadrine—Vomiting—Acetazolamide—epilepsy syndrome	9.17e-05	0.00164	CcSEcCtD
Orphenadrine—KCNH2—head—epilepsy syndrome	9.17e-05	0.0033	CbGeAlD
Orphenadrine—Pruritus—Levetiracetam—epilepsy syndrome	9.16e-05	0.00164	CcSEcCtD
Orphenadrine—Tremor—Valproic Acid—epilepsy syndrome	9.15e-05	0.00164	CcSEcCtD
Orphenadrine—Headache—Acetazolamide—epilepsy syndrome	9.04e-05	0.00162	CcSEcCtD
Orphenadrine—Urticaria—Zonisamide—epilepsy syndrome	9.03e-05	0.00162	CcSEcCtD
Orphenadrine—Feeling abnormal—Clonazepam—epilepsy syndrome	9.02e-05	0.00162	CcSEcCtD
Orphenadrine—Agitation—Valproic Acid—epilepsy syndrome	8.98e-05	0.00161	CcSEcCtD
Orphenadrine—Hypersensitivity—Vigabatrin—epilepsy syndrome	8.98e-05	0.00161	CcSEcCtD
Orphenadrine—Asthenia—Fosphenytoin—epilepsy syndrome	8.97e-05	0.00161	CcSEcCtD
Orphenadrine—Feeling abnormal—Phenytoin—epilepsy syndrome	8.96e-05	0.00161	CcSEcCtD
Orphenadrine—Somnolence—Lamotrigine—epilepsy syndrome	8.92e-05	0.0016	CcSEcCtD
Orphenadrine—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	8.92e-05	0.0016	CcSEcCtD
Orphenadrine—CYP2E1—medulla oblongata—epilepsy syndrome	8.91e-05	0.00321	CbGeAlD
Orphenadrine—Constipation—Carbamazepine—epilepsy syndrome	8.88e-05	0.00159	CcSEcCtD
Orphenadrine—Dizziness—Propofol—epilepsy syndrome	8.86e-05	0.00159	CcSEcCtD
Orphenadrine—Pruritus—Fosphenytoin—epilepsy syndrome	8.84e-05	0.00158	CcSEcCtD
Orphenadrine—Hypersensitivity—Diazepam—epilepsy syndrome	8.84e-05	0.00158	CcSEcCtD
Orphenadrine—Asthenia—Vigabatrin—epilepsy syndrome	8.74e-05	0.00157	CcSEcCtD
Orphenadrine—Urticaria—Clonazepam—epilepsy syndrome	8.7e-05	0.00156	CcSEcCtD
Orphenadrine—KCNH2—nervous system—epilepsy syndrome	8.69e-05	0.00313	CbGeAlD
Orphenadrine—Dizziness—Midazolam—epilepsy syndrome	8.67e-05	0.00155	CcSEcCtD
Orphenadrine—Tension—Pregabalin—epilepsy syndrome	8.67e-05	0.00155	CcSEcCtD
Orphenadrine—Urticaria—Phenytoin—epilepsy syndrome	8.64e-05	0.00155	CcSEcCtD
Orphenadrine—Palpitations—Valproic Acid—epilepsy syndrome	8.63e-05	0.00155	CcSEcCtD
Orphenadrine—Pruritus—Vigabatrin—epilepsy syndrome	8.62e-05	0.00154	CcSEcCtD
Orphenadrine—Asthenia—Diazepam—epilepsy syndrome	8.6e-05	0.00154	CcSEcCtD
Orphenadrine—Urticaria—Oxcarbazepine—epilepsy syndrome	8.6e-05	0.00154	CcSEcCtD
Orphenadrine—Constipation—Lamotrigine—epilepsy syndrome	8.58e-05	0.00154	CcSEcCtD
Orphenadrine—Nausea—Acetazolamide—epilepsy syndrome	8.57e-05	0.00154	CcSEcCtD
Orphenadrine—Dizziness—Levetiracetam—epilepsy syndrome	8.56e-05	0.00153	CcSEcCtD
Orphenadrine—Feeling abnormal—Carbamazepine—epilepsy syndrome	8.56e-05	0.00153	CcSEcCtD
Orphenadrine—Vomiting—Propofol—epilepsy syndrome	8.52e-05	0.00153	CcSEcCtD
Orphenadrine—Pruritus—Diazepam—epilepsy syndrome	8.49e-05	0.00152	CcSEcCtD
Orphenadrine—Headache—Propofol—epilepsy syndrome	8.4e-05	0.0015	CcSEcCtD
Orphenadrine—Hypersensitivity—Zonisamide—epilepsy syndrome	8.37e-05	0.0015	CcSEcCtD
Orphenadrine—KCNH2—central nervous system—epilepsy syndrome	8.37e-05	0.00301	CbGeAlD
Orphenadrine—Vomiting—Midazolam—epilepsy syndrome	8.34e-05	0.00149	CcSEcCtD
Orphenadrine—Asthenia—Felbamate—epilepsy syndrome	8.33e-05	0.00149	CcSEcCtD
Orphenadrine—Vision blurred—Pregabalin—epilepsy syndrome	8.32e-05	0.00149	CcSEcCtD
Orphenadrine—Tremor—Pregabalin—epilepsy syndrome	8.28e-05	0.00148	CcSEcCtD
Orphenadrine—Feeling abnormal—Lamotrigine—epilepsy syndrome	8.27e-05	0.00148	CcSEcCtD
Orphenadrine—Dizziness—Fosphenytoin—epilepsy syndrome	8.26e-05	0.00148	CcSEcCtD
Orphenadrine—Urticaria—Carbamazepine—epilepsy syndrome	8.25e-05	0.00148	CcSEcCtD
Orphenadrine—Vomiting—Levetiracetam—epilepsy syndrome	8.23e-05	0.00147	CcSEcCtD
Orphenadrine—Headache—Midazolam—epilepsy syndrome	8.21e-05	0.00147	CcSEcCtD
Orphenadrine—Pruritus—Felbamate—epilepsy syndrome	8.21e-05	0.00147	CcSEcCtD
Orphenadrine—KCNH2—cerebellum—epilepsy syndrome	8.18e-05	0.00294	CbGeAlD
Orphenadrine—Asthenia—Zonisamide—epilepsy syndrome	8.15e-05	0.00146	CcSEcCtD
Orphenadrine—Agitation—Pregabalin—epilepsy syndrome	8.12e-05	0.00145	CcSEcCtD
Orphenadrine—Headache—Levetiracetam—epilepsy syndrome	8.11e-05	0.00145	CcSEcCtD
Orphenadrine—Hypersensitivity—Clonazepam—epilepsy syndrome	8.07e-05	0.00145	CcSEcCtD
Orphenadrine—Dizziness—Vigabatrin—epilepsy syndrome	8.06e-05	0.00144	CcSEcCtD
Orphenadrine—Confusional state—Valproic Acid—epilepsy syndrome	8.04e-05	0.00144	CcSEcCtD
Orphenadrine—Pruritus—Zonisamide—epilepsy syndrome	8.04e-05	0.00144	CcSEcCtD
Orphenadrine—Hypersensitivity—Phenytoin—epilepsy syndrome	8.01e-05	0.00144	CcSEcCtD
Orphenadrine—Anaphylactic shock—Valproic Acid—epilepsy syndrome	7.97e-05	0.00143	CcSEcCtD
Orphenadrine—Urticaria—Lamotrigine—epilepsy syndrome	7.97e-05	0.00143	CcSEcCtD
Orphenadrine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	7.97e-05	0.00143	CcSEcCtD
Orphenadrine—Nausea—Propofol—epilepsy syndrome	7.96e-05	0.00143	CcSEcCtD
Orphenadrine—Tension—Gabapentin—epilepsy syndrome	7.95e-05	0.00142	CcSEcCtD
Orphenadrine—Vomiting—Fosphenytoin—epilepsy syndrome	7.95e-05	0.00142	CcSEcCtD
Orphenadrine—CYP2E1—spinal cord—epilepsy syndrome	7.95e-05	0.00286	CbGeAlD
Orphenadrine—Dizziness—Diazepam—epilepsy syndrome	7.93e-05	0.00142	CcSEcCtD
Orphenadrine—Asthenia—Clonazepam—epilepsy syndrome	7.86e-05	0.00141	CcSEcCtD
Orphenadrine—Headache—Fosphenytoin—epilepsy syndrome	7.83e-05	0.0014	CcSEcCtD
Orphenadrine—Palpitations—Pregabalin—epilepsy syndrome	7.81e-05	0.0014	CcSEcCtD
Orphenadrine—Asthenia—Phenytoin—epilepsy syndrome	7.8e-05	0.0014	CcSEcCtD
Orphenadrine—Nausea—Midazolam—epilepsy syndrome	7.79e-05	0.0014	CcSEcCtD
Orphenadrine—Hallucination—Topiramate—epilepsy syndrome	7.79e-05	0.00139	CcSEcCtD
Orphenadrine—Tachycardia—Valproic Acid—epilepsy syndrome	7.78e-05	0.00139	CcSEcCtD
Orphenadrine—Asthenia—Oxcarbazepine—epilepsy syndrome	7.76e-05	0.00139	CcSEcCtD
Orphenadrine—Pruritus—Clonazepam—epilepsy syndrome	7.75e-05	0.00139	CcSEcCtD
Orphenadrine—Vomiting—Vigabatrin—epilepsy syndrome	7.75e-05	0.00139	CcSEcCtD
Orphenadrine—Skin disorder—Valproic Acid—epilepsy syndrome	7.75e-05	0.00139	CcSEcCtD
Orphenadrine—Pruritus—Phenytoin—epilepsy syndrome	7.7e-05	0.00138	CcSEcCtD
Orphenadrine—Nausea—Levetiracetam—epilepsy syndrome	7.69e-05	0.00138	CcSEcCtD
Orphenadrine—Dizziness—Felbamate—epilepsy syndrome	7.68e-05	0.00137	CcSEcCtD
Orphenadrine—Pruritus—Oxcarbazepine—epilepsy syndrome	7.65e-05	0.00137	CcSEcCtD
Orphenadrine—Hypersensitivity—Carbamazepine—epilepsy syndrome	7.65e-05	0.00137	CcSEcCtD
Orphenadrine—Vision blurred—Gabapentin—epilepsy syndrome	7.63e-05	0.00137	CcSEcCtD
Orphenadrine—Headache—Vigabatrin—epilepsy syndrome	7.63e-05	0.00137	CcSEcCtD
Orphenadrine—Vomiting—Diazepam—epilepsy syndrome	7.63e-05	0.00137	CcSEcCtD
Orphenadrine—Tremor—Gabapentin—epilepsy syndrome	7.59e-05	0.00136	CcSEcCtD
Orphenadrine—CYP2B6—head—epilepsy syndrome	7.53e-05	0.00271	CbGeAlD
Orphenadrine—Dizziness—Zonisamide—epilepsy syndrome	7.51e-05	0.00135	CcSEcCtD
Orphenadrine—Headache—Diazepam—epilepsy syndrome	7.51e-05	0.00135	CcSEcCtD
Orphenadrine—Asthenia—Carbamazepine—epilepsy syndrome	7.45e-05	0.00133	CcSEcCtD
Orphenadrine—Agitation—Gabapentin—epilepsy syndrome	7.44e-05	0.00133	CcSEcCtD
Orphenadrine—Nausea—Fosphenytoin—epilepsy syndrome	7.42e-05	0.00133	CcSEcCtD
Orphenadrine—SLC6A2—brain—epilepsy syndrome	7.4e-05	0.00266	CbGeAlD
Orphenadrine—Hypersensitivity—Lamotrigine—epilepsy syndrome	7.39e-05	0.00132	CcSEcCtD
Orphenadrine—Vomiting—Felbamate—epilepsy syndrome	7.38e-05	0.00132	CcSEcCtD
Orphenadrine—HRH1—head—epilepsy syndrome	7.35e-05	0.00264	CbGeAlD
Orphenadrine—Pruritus—Carbamazepine—epilepsy syndrome	7.35e-05	0.00132	CcSEcCtD
Orphenadrine—Headache—Felbamate—epilepsy syndrome	7.27e-05	0.0013	CcSEcCtD
Orphenadrine—Confusional state—Pregabalin—epilepsy syndrome	7.27e-05	0.0013	CcSEcCtD
Orphenadrine—Dizziness—Clonazepam—epilepsy syndrome	7.24e-05	0.0013	CcSEcCtD
Orphenadrine—Nausea—Vigabatrin—epilepsy syndrome	7.24e-05	0.0013	CcSEcCtD
Orphenadrine—Vomiting—Zonisamide—epilepsy syndrome	7.22e-05	0.00129	CcSEcCtD
Orphenadrine—Anaphylactic shock—Pregabalin—epilepsy syndrome	7.21e-05	0.00129	CcSEcCtD
Orphenadrine—Asthenia—Lamotrigine—epilepsy syndrome	7.2e-05	0.00129	CcSEcCtD
Orphenadrine—Dizziness—Phenytoin—epilepsy syndrome	7.19e-05	0.00129	CcSEcCtD
Orphenadrine—Palpitations—Gabapentin—epilepsy syndrome	7.16e-05	0.00128	CcSEcCtD
Orphenadrine—Dizziness—Oxcarbazepine—epilepsy syndrome	7.15e-05	0.00128	CcSEcCtD
Orphenadrine—CYP2B6—nervous system—epilepsy syndrome	7.13e-05	0.00257	CbGeAlD
Orphenadrine—Nausea—Diazepam—epilepsy syndrome	7.12e-05	0.00128	CcSEcCtD
Orphenadrine—Headache—Zonisamide—epilepsy syndrome	7.12e-05	0.00127	CcSEcCtD
Orphenadrine—Pruritus—Lamotrigine—epilepsy syndrome	7.1e-05	0.00127	CcSEcCtD
Orphenadrine—Somnolence—Valproic Acid—epilepsy syndrome	7.09e-05	0.00127	CcSEcCtD
Orphenadrine—CYP2E1—head—epilepsy syndrome	7.06e-05	0.00254	CbGeAlD
Orphenadrine—Methadyl Acetate—OPRM1—epilepsy syndrome	7.05e-05	0.0301	CrCbGaD
Orphenadrine—Tachycardia—Pregabalin—epilepsy syndrome	7.04e-05	0.00126	CcSEcCtD
Orphenadrine—Skin disorder—Pregabalin—epilepsy syndrome	7e-05	0.00125	CcSEcCtD
Orphenadrine—HRH1—nervous system—epilepsy syndrome	6.97e-05	0.00251	CbGeAlD
Orphenadrine—Vomiting—Clonazepam—epilepsy syndrome	6.96e-05	0.00125	CcSEcCtD
Orphenadrine—Vomiting—Phenytoin—epilepsy syndrome	6.92e-05	0.00124	CcSEcCtD
Orphenadrine—Nausea—Felbamate—epilepsy syndrome	6.89e-05	0.00123	CcSEcCtD
Orphenadrine—Vomiting—Oxcarbazepine—epilepsy syndrome	6.88e-05	0.00123	CcSEcCtD
Orphenadrine—CYP2B6—central nervous system—epilepsy syndrome	6.87e-05	0.00247	CbGeAlD
Orphenadrine—Dizziness—Carbamazepine—epilepsy syndrome	6.87e-05	0.00123	CcSEcCtD
Orphenadrine—Headache—Clonazepam—epilepsy syndrome	6.86e-05	0.00123	CcSEcCtD
Orphenadrine—Constipation—Valproic Acid—epilepsy syndrome	6.82e-05	0.00122	CcSEcCtD
Orphenadrine—Headache—Phenytoin—epilepsy syndrome	6.81e-05	0.00122	CcSEcCtD
Orphenadrine—Dimenhydrinate—CHRM2—epilepsy syndrome	6.8e-05	0.029	CrCbGaD
Orphenadrine—Headache—Oxcarbazepine—epilepsy syndrome	6.78e-05	0.00121	CcSEcCtD
Orphenadrine—Nausea—Zonisamide—epilepsy syndrome	6.75e-05	0.00121	CcSEcCtD
Orphenadrine—HRH1—central nervous system—epilepsy syndrome	6.71e-05	0.00241	CbGeAlD
Orphenadrine—CYP2E1—nervous system—epilepsy syndrome	6.7e-05	0.00241	CbGeAlD
Orphenadrine—Tension—Topiramate—epilepsy syndrome	6.69e-05	0.0012	CcSEcCtD
Orphenadrine—Confusional state—Gabapentin—epilepsy syndrome	6.67e-05	0.00119	CcSEcCtD
Orphenadrine—KCNH2—brain—epilepsy syndrome	6.64e-05	0.00239	CbGeAlD
Orphenadrine—Dizziness—Lamotrigine—epilepsy syndrome	6.64e-05	0.00119	CcSEcCtD
Orphenadrine—Anaphylactic shock—Gabapentin—epilepsy syndrome	6.61e-05	0.00118	CcSEcCtD
Orphenadrine—Vomiting—Carbamazepine—epilepsy syndrome	6.6e-05	0.00118	CcSEcCtD
Orphenadrine—Feeling abnormal—Valproic Acid—epilepsy syndrome	6.57e-05	0.00118	CcSEcCtD
Orphenadrine—Cyclopentolate—CHRM3—epilepsy syndrome	6.56e-05	0.028	CrCbGaD
Orphenadrine—Nausea—Clonazepam—epilepsy syndrome	6.5e-05	0.00117	CcSEcCtD
Orphenadrine—Headache—Carbamazepine—epilepsy syndrome	6.5e-05	0.00117	CcSEcCtD
Orphenadrine—Nausea—Phenytoin—epilepsy syndrome	6.46e-05	0.00116	CcSEcCtD
Orphenadrine—Tachycardia—Gabapentin—epilepsy syndrome	6.45e-05	0.00116	CcSEcCtD
Orphenadrine—CYP2E1—central nervous system—epilepsy syndrome	6.45e-05	0.00232	CbGeAlD
Orphenadrine—Nausea—Oxcarbazepine—epilepsy syndrome	6.43e-05	0.00115	CcSEcCtD
Orphenadrine—Vision blurred—Topiramate—epilepsy syndrome	6.42e-05	0.00115	CcSEcCtD
Orphenadrine—Skin disorder—Gabapentin—epilepsy syndrome	6.42e-05	0.00115	CcSEcCtD
Orphenadrine—Somnolence—Pregabalin—epilepsy syndrome	6.41e-05	0.00115	CcSEcCtD
Orphenadrine—Tremor—Topiramate—epilepsy syndrome	6.38e-05	0.00114	CcSEcCtD
Orphenadrine—Vomiting—Lamotrigine—epilepsy syndrome	6.38e-05	0.00114	CcSEcCtD
Orphenadrine—Urticaria—Valproic Acid—epilepsy syndrome	6.33e-05	0.00113	CcSEcCtD
Orphenadrine—CYP2E1—cerebellum—epilepsy syndrome	6.3e-05	0.00227	CbGeAlD
Orphenadrine—Headache—Lamotrigine—epilepsy syndrome	6.29e-05	0.00113	CcSEcCtD
Orphenadrine—Agitation—Topiramate—epilepsy syndrome	6.26e-05	0.00112	CcSEcCtD
Orphenadrine—Nausea—Carbamazepine—epilepsy syndrome	6.17e-05	0.0011	CcSEcCtD
Orphenadrine—Constipation—Pregabalin—epilepsy syndrome	6.16e-05	0.0011	CcSEcCtD
Orphenadrine—Cyclopentolate—CHRM1—epilepsy syndrome	6.12e-05	0.0261	CrCbGaD
Orphenadrine—Palpitations—Topiramate—epilepsy syndrome	6.02e-05	0.00108	CcSEcCtD
Orphenadrine—Nausea—Lamotrigine—epilepsy syndrome	5.96e-05	0.00107	CcSEcCtD
Orphenadrine—Feeling abnormal—Pregabalin—epilepsy syndrome	5.94e-05	0.00106	CcSEcCtD
Orphenadrine—Somnolence—Gabapentin—epilepsy syndrome	5.88e-05	0.00105	CcSEcCtD
Orphenadrine—Hypersensitivity—Valproic Acid—epilepsy syndrome	5.87e-05	0.00105	CcSEcCtD
Orphenadrine—Urticaria—Pregabalin—epilepsy syndrome	5.73e-05	0.00103	CcSEcCtD
Orphenadrine—Asthenia—Valproic Acid—epilepsy syndrome	5.72e-05	0.00102	CcSEcCtD
Orphenadrine—Imipramine—KCND2—epilepsy syndrome	5.69e-05	0.0242	CrCbGaD
Orphenadrine—Constipation—Gabapentin—epilepsy syndrome	5.65e-05	0.00101	CcSEcCtD
Orphenadrine—Amitriptyline—KCND2—epilepsy syndrome	5.65e-05	0.0241	CrCbGaD
Orphenadrine—Pruritus—Valproic Acid—epilepsy syndrome	5.64e-05	0.00101	CcSEcCtD
Orphenadrine—Confusional state—Topiramate—epilepsy syndrome	5.61e-05	0.001	CcSEcCtD
Orphenadrine—CYP2B6—brain—epilepsy syndrome	5.45e-05	0.00196	CbGeAlD
Orphenadrine—Feeling abnormal—Gabapentin—epilepsy syndrome	5.45e-05	0.000976	CcSEcCtD
Orphenadrine—Tachycardia—Topiramate—epilepsy syndrome	5.43e-05	0.000972	CcSEcCtD
Orphenadrine—Skin disorder—Topiramate—epilepsy syndrome	5.4e-05	0.000968	CcSEcCtD
Orphenadrine—CYP3A4—nervous system—epilepsy syndrome	5.39e-05	0.00194	CbGeAlD
Orphenadrine—HRH1—brain—epilepsy syndrome	5.33e-05	0.00192	CbGeAlD
Orphenadrine—Hypersensitivity—Pregabalin—epilepsy syndrome	5.31e-05	0.000951	CcSEcCtD
Orphenadrine—Dizziness—Valproic Acid—epilepsy syndrome	5.27e-05	0.000944	CcSEcCtD
Orphenadrine—Amitriptyline—KCNQ3—epilepsy syndrome	5.25e-05	0.0224	CrCbGaD
Orphenadrine—Amitriptyline—KCNQ2—epilepsy syndrome	5.25e-05	0.0224	CrCbGaD
Orphenadrine—Urticaria—Gabapentin—epilepsy syndrome	5.25e-05	0.000941	CcSEcCtD
Orphenadrine—CYP3A4—central nervous system—epilepsy syndrome	5.19e-05	0.00187	CbGeAlD
Orphenadrine—Asthenia—Pregabalin—epilepsy syndrome	5.17e-05	0.000926	CcSEcCtD
Orphenadrine—Doxylamine—CHRM1—epilepsy syndrome	5.15e-05	0.0219	CrCbGaD
Orphenadrine—CYP2E1—brain—epilepsy syndrome	5.12e-05	0.00184	CbGeAlD
Orphenadrine—Pruritus—Pregabalin—epilepsy syndrome	5.1e-05	0.000913	CcSEcCtD
Orphenadrine—Vomiting—Valproic Acid—epilepsy syndrome	5.07e-05	0.000908	CcSEcCtD
Orphenadrine—Headache—Valproic Acid—epilepsy syndrome	5e-05	0.000895	CcSEcCtD
Orphenadrine—Somnolence—Topiramate—epilepsy syndrome	4.94e-05	0.000886	CcSEcCtD
Orphenadrine—Hypersensitivity—Gabapentin—epilepsy syndrome	4.87e-05	0.000872	CcSEcCtD
Orphenadrine—Dizziness—Pregabalin—epilepsy syndrome	4.77e-05	0.000854	CcSEcCtD
Orphenadrine—Constipation—Topiramate—epilepsy syndrome	4.76e-05	0.000852	CcSEcCtD
Orphenadrine—Asthenia—Gabapentin—epilepsy syndrome	4.74e-05	0.000849	CcSEcCtD
Orphenadrine—Nausea—Valproic Acid—epilepsy syndrome	4.74e-05	0.000848	CcSEcCtD
Orphenadrine—Pruritus—Gabapentin—epilepsy syndrome	4.68e-05	0.000838	CcSEcCtD
Orphenadrine—Vomiting—Pregabalin—epilepsy syndrome	4.58e-05	0.000821	CcSEcCtD
Orphenadrine—Feeling abnormal—Topiramate—epilepsy syndrome	4.58e-05	0.000821	CcSEcCtD
Orphenadrine—Headache—Pregabalin—epilepsy syndrome	4.52e-05	0.000809	CcSEcCtD
Orphenadrine—Amitriptyline—NTRK2—epilepsy syndrome	4.47e-05	0.019	CrCbGaD
Orphenadrine—Urticaria—Topiramate—epilepsy syndrome	4.42e-05	0.000791	CcSEcCtD
Orphenadrine—Dizziness—Gabapentin—epilepsy syndrome	4.37e-05	0.000783	CcSEcCtD
Orphenadrine—Nausea—Pregabalin—epilepsy syndrome	4.28e-05	0.000767	CcSEcCtD
Orphenadrine—Vomiting—Gabapentin—epilepsy syndrome	4.2e-05	0.000753	CcSEcCtD
Orphenadrine—Tolterodine—CHRM3—epilepsy syndrome	4.18e-05	0.0178	CrCbGaD
Orphenadrine—Cyclopentolate—BCHE—epilepsy syndrome	4.17e-05	0.0178	CrCbGaD
Orphenadrine—Headache—Gabapentin—epilepsy syndrome	4.14e-05	0.000742	CcSEcCtD
Orphenadrine—Hypersensitivity—Topiramate—epilepsy syndrome	4.1e-05	0.000734	CcSEcCtD
Orphenadrine—Asthenia—Topiramate—epilepsy syndrome	3.99e-05	0.000715	CcSEcCtD
Orphenadrine—Pruritus—Topiramate—epilepsy syndrome	3.93e-05	0.000705	CcSEcCtD
Orphenadrine—Nausea—Gabapentin—epilepsy syndrome	3.93e-05	0.000703	CcSEcCtD
Orphenadrine—Tolterodine—CHRM1—epilepsy syndrome	3.9e-05	0.0166	CrCbGaD
Orphenadrine—Benzatropine—CHRM1—epilepsy syndrome	3.76e-05	0.016	CrCbGaD
Orphenadrine—Ethopropazine—CHRM1—epilepsy syndrome	3.71e-05	0.0158	CrCbGaD
Orphenadrine—Dizziness—Topiramate—epilepsy syndrome	3.68e-05	0.000659	CcSEcCtD
Orphenadrine—Dimetindene—CHRM2—epilepsy syndrome	3.67e-05	0.0157	CrCbGaD
Orphenadrine—Vomiting—Topiramate—epilepsy syndrome	3.54e-05	0.000633	CcSEcCtD
Orphenadrine—Headache—Topiramate—epilepsy syndrome	3.48e-05	0.000624	CcSEcCtD
Orphenadrine—Dextropropoxyphene—OPRD1—epilepsy syndrome	3.47e-05	0.0148	CrCbGaD
Orphenadrine—Nausea—Topiramate—epilepsy syndrome	3.3e-05	0.000592	CcSEcCtD
Orphenadrine—Tolterodine—CHRM2—epilepsy syndrome	3.19e-05	0.0136	CrCbGaD
Orphenadrine—Reboxetine—SLC6A4—epilepsy syndrome	3.16e-05	0.0135	CrCbGaD
Orphenadrine—Brompheniramine—CHRM3—epilepsy syndrome	3.11e-05	0.0133	CrCbGaD
Orphenadrine—Levomethadyl Acetate—OPRM1—epilepsy syndrome	3.07e-05	0.0131	CrCbGaD
Orphenadrine—Benzatropine—CHRM2—epilepsy syndrome	3.07e-05	0.0131	CrCbGaD
Orphenadrine—Ethopropazine—CHRM2—epilepsy syndrome	3.03e-05	0.0129	CrCbGaD
Orphenadrine—Brompheniramine—CHRM1—epilepsy syndrome	2.9e-05	0.0124	CrCbGaD
Orphenadrine—Dextropropoxyphene—OPRM1—epilepsy syndrome	2.65e-05	0.0113	CrCbGaD
Orphenadrine—Ethopropazine—BCHE—epilepsy syndrome	2.53e-05	0.0108	CrCbGaD
Orphenadrine—Brompheniramine—CHRM2—epilepsy syndrome	2.37e-05	0.0101	CrCbGaD
Orphenadrine—Methadone—OPRD1—epilepsy syndrome	2.35e-05	0.01	CrCbGaD
Orphenadrine—Reboxetine—CYP2D6—epilepsy syndrome	2.22e-05	0.00946	CrCbGaD
Orphenadrine—Promethazine—CHRM3—epilepsy syndrome	2.03e-05	0.00866	CrCbGaD
Orphenadrine—Doxepin—CHRM3—epilepsy syndrome	2.01e-05	0.00857	CrCbGaD
Orphenadrine—Fluoxetine—SLC6A4—epilepsy syndrome	1.98e-05	0.00843	CrCbGaD
Orphenadrine—Mepyramine—CYP2D6—epilepsy syndrome	1.98e-05	0.00843	CrCbGaD
Orphenadrine—Tolterodine—CYP2C19—epilepsy syndrome	1.97e-05	0.00838	CrCbGaD
Orphenadrine—Promethazine—CHRM1—epilepsy syndrome	1.89e-05	0.00807	CrCbGaD
Orphenadrine—Benzatropine—CYP2C19—epilepsy syndrome	1.89e-05	0.00807	CrCbGaD
Orphenadrine—Fluoxetine—CYP2C19—epilepsy syndrome	1.88e-05	0.008	CrCbGaD
Orphenadrine—Doxepin—CHRM1—epilepsy syndrome	1.87e-05	0.00799	CrCbGaD
Orphenadrine—Tripelennamine—CYP2D6—epilepsy syndrome	1.83e-05	0.0078	CrCbGaD
Orphenadrine—Amitriptyline—OPRD1—epilepsy syndrome	1.83e-05	0.00779	CrCbGaD
Orphenadrine—Methadone—OPRM1—epilepsy syndrome	1.8e-05	0.00767	CrCbGaD
Orphenadrine—Aprindine—CYP2D6—epilepsy syndrome	1.79e-05	0.00762	CrCbGaD
Orphenadrine—Promazine—CHRM3—epilepsy syndrome	1.79e-05	0.00762	CrCbGaD
Orphenadrine—Warfarin—CYP2C19—epilepsy syndrome	1.71e-05	0.00729	CrCbGaD
Orphenadrine—Carbinoxamine—CYP2C19—epilepsy syndrome	1.69e-05	0.00719	CrCbGaD
Orphenadrine—Benzphetamine—ADRA2A—epilepsy syndrome	1.68e-05	0.00716	CrCbGaD
Orphenadrine—Promazine—CHRM1—epilepsy syndrome	1.67e-05	0.0071	CrCbGaD
Orphenadrine—Cyclobenzaprine—HTR2A—epilepsy syndrome	1.66e-05	0.00709	CrCbGaD
Orphenadrine—Phenoxybenzamine—ADRA2A—epilepsy syndrome	1.61e-05	0.00684	CrCbGaD
Orphenadrine—Reboxetine—ABCB1—epilepsy syndrome	1.58e-05	0.00675	CrCbGaD
Orphenadrine—Diphenhydramine—CHRM2—epilepsy syndrome	1.58e-05	0.00672	CrCbGaD
Orphenadrine—Imipramine—CHRM3—epilepsy syndrome	1.56e-05	0.00667	CrCbGaD
Orphenadrine—Amitriptyline—CHRM3—epilepsy syndrome	1.55e-05	0.00663	CrCbGaD
Orphenadrine—Promethazine—CHRM2—epilepsy syndrome	1.55e-05	0.00659	CrCbGaD
Orphenadrine—Doxepin—CHRM2—epilepsy syndrome	1.53e-05	0.00652	CrCbGaD
Orphenadrine—Fluoxetine—HTR2A—epilepsy syndrome	1.52e-05	0.00648	CrCbGaD
Orphenadrine—Cyclobenzaprine—CYP2D6—epilepsy syndrome	1.52e-05	0.00648	CrCbGaD
Orphenadrine—Chlorphenamine—SLC6A4—epilepsy syndrome	1.51e-05	0.00645	CrCbGaD
Orphenadrine—Brompheniramine—CYP2C19—epilepsy syndrome	1.46e-05	0.00623	CrCbGaD
Orphenadrine—Imipramine—CHRM1—epilepsy syndrome	1.46e-05	0.00622	CrCbGaD
Orphenadrine—Tolterodine—CYP2D6—epilepsy syndrome	1.46e-05	0.00621	CrCbGaD
Orphenadrine—Amitriptyline—CHRM1—epilepsy syndrome	1.45e-05	0.00618	CrCbGaD
Orphenadrine—Benzatropine—CYP2D6—epilepsy syndrome	1.4e-05	0.00598	CrCbGaD
Orphenadrine—Modafinil—CYP2C19—epilepsy syndrome	1.4e-05	0.00597	CrCbGaD
Orphenadrine—Amitriptyline—OPRM1—epilepsy syndrome	1.4e-05	0.00596	CrCbGaD
Orphenadrine—Fenoprofen—PTGS2—epilepsy syndrome	1.39e-05	0.00593	CrCbGaD
Orphenadrine—Fluoxetine—CYP2D6—epilepsy syndrome	1.39e-05	0.00593	CrCbGaD
Orphenadrine—Trimipramine—ADRA2A—epilepsy syndrome	1.37e-05	0.00584	CrCbGaD
Orphenadrine—Tamoxifen—ABCC2—epilepsy syndrome	1.36e-05	0.00581	CrCbGaD
Orphenadrine—Promazine—CHRM2—epilepsy syndrome	1.36e-05	0.0058	CrCbGaD
Orphenadrine—Doxepin—ADRA2A—epilepsy syndrome	1.31e-05	0.00557	CrCbGaD
Orphenadrine—Atomoxetine—SLC6A4—epilepsy syndrome	1.27e-05	0.00542	CrCbGaD
Orphenadrine—Toremifene—ABCB1—epilepsy syndrome	1.26e-05	0.00535	CrCbGaD
Orphenadrine—Carbinoxamine—CYP2D6—epilepsy syndrome	1.25e-05	0.00533	CrCbGaD
Orphenadrine—Fenoprofen—ALB—epilepsy syndrome	1.24e-05	0.00529	CrCbGaD
Orphenadrine—Tamoxifen—ABCG2—epilepsy syndrome	1.21e-05	0.00514	CrCbGaD
Orphenadrine—Atomoxetine—CYP2C19—epilepsy syndrome	1.21e-05	0.00514	CrCbGaD
Orphenadrine—Imipramine—CHRM2—epilepsy syndrome	1.19e-05	0.00508	CrCbGaD
Orphenadrine—Imipramine—HTR7—epilepsy syndrome	1.19e-05	0.00505	CrCbGaD
Orphenadrine—Amitriptyline—CHRM2—epilepsy syndrome	1.18e-05	0.00505	CrCbGaD
Orphenadrine—Amitriptyline—HTR7—epilepsy syndrome	1.18e-05	0.00502	CrCbGaD
Orphenadrine—Promazine—ADRA2A—epilepsy syndrome	1.16e-05	0.00495	CrCbGaD
Orphenadrine—Brompheniramine—CYP2D6—epilepsy syndrome	1.08e-05	0.00462	CrCbGaD
Orphenadrine—Phenprocoumon—ALB—epilepsy syndrome	1.07e-05	0.00456	CrCbGaD
Orphenadrine—Chlorphenamine—CYP2D6—epilepsy syndrome	1.06e-05	0.00453	CrCbGaD
Orphenadrine—Trimipramine—SLC6A4—epilepsy syndrome	1.05e-05	0.00446	CrCbGaD
Orphenadrine—Fluoxetine—ALB—epilepsy syndrome	1.04e-05	0.00444	CrCbGaD
Orphenadrine—Dextropropoxyphene—CYP2D6—epilepsy syndrome	1.03e-05	0.00438	CrCbGaD
Orphenadrine—Amitriptyline—ADRA2A—epilepsy syndrome	1.01e-05	0.00431	CrCbGaD
Orphenadrine—Doxepin—SLC6A4—epilepsy syndrome	9.97e-06	0.00425	CrCbGaD
Orphenadrine—Fluoxetine—ABCB1—epilepsy syndrome	9.93e-06	0.00423	CrCbGaD
Orphenadrine—Trimipramine—CYP2C19—epilepsy syndrome	9.91e-06	0.00423	CrCbGaD
Orphenadrine—Atomoxetine—HTR2A—epilepsy syndrome	9.77e-06	0.00416	CrCbGaD
Orphenadrine—Diphenhydramine—CYP2C19—epilepsy syndrome	9.73e-06	0.00415	CrCbGaD
Orphenadrine—Warfarin—ALB—epilepsy syndrome	9.49e-06	0.00404	CrCbGaD
Orphenadrine—Tamoxifen—CYP2C19—epilepsy syndrome	9.48e-06	0.00404	CrCbGaD
Orphenadrine—Doxepin—CYP2C19—epilepsy syndrome	9.45e-06	0.00403	CrCbGaD
Orphenadrine—Methadone—CYP2C19—epilepsy syndrome	9.4e-06	0.00401	CrCbGaD
Orphenadrine—Atomoxetine—CYP2D6—epilepsy syndrome	8.93e-06	0.00381	CrCbGaD
Orphenadrine—Promazine—CYP2C19—epilepsy syndrome	8.4e-06	0.00358	CrCbGaD
Orphenadrine—Trimipramine—HTR2A—epilepsy syndrome	8.04e-06	0.00343	CrCbGaD
Orphenadrine—Imipramine—SLC6A4—epilepsy syndrome	7.75e-06	0.00331	CrCbGaD
Orphenadrine—Promethazine—HTR2A—epilepsy syndrome	7.74e-06	0.0033	CrCbGaD
Orphenadrine—Amitriptyline—SLC6A4—epilepsy syndrome	7.71e-06	0.00329	CrCbGaD
Orphenadrine—Doxepin—HTR2A—epilepsy syndrome	7.66e-06	0.00326	CrCbGaD
Orphenadrine—Imipramine—CYP2C19—epilepsy syndrome	7.35e-06	0.00313	CrCbGaD
Orphenadrine—Trimipramine—CYP2D6—epilepsy syndrome	7.35e-06	0.00313	CrCbGaD
Orphenadrine—Amitriptyline—CYP2C19—epilepsy syndrome	7.31e-06	0.00311	CrCbGaD
Orphenadrine—Diphenhydramine—CYP2D6—epilepsy syndrome	7.22e-06	0.00308	CrCbGaD
Orphenadrine—Promethazine—CYP2D6—epilepsy syndrome	7.08e-06	0.00302	CrCbGaD
Orphenadrine—Tamoxifen—CYP2D6—epilepsy syndrome	7.03e-06	0.003	CrCbGaD
Orphenadrine—Doxepin—CYP2D6—epilepsy syndrome	7e-06	0.00299	CrCbGaD
Orphenadrine—Methadone—CYP2D6—epilepsy syndrome	6.97e-06	0.00297	CrCbGaD
Orphenadrine—Promazine—HTR2A—epilepsy syndrome	6.81e-06	0.0029	CrCbGaD
Orphenadrine—Imipramine—HTR2A—epilepsy syndrome	5.96e-06	0.00254	CrCbGaD
Orphenadrine—Amitriptyline—HTR2A—epilepsy syndrome	5.92e-06	0.00252	CrCbGaD
Orphenadrine—Imipramine—CYP2D6—epilepsy syndrome	5.45e-06	0.00232	CrCbGaD
Orphenadrine—Amitriptyline—CYP2D6—epilepsy syndrome	5.42e-06	0.00231	CrCbGaD
Orphenadrine—Trimipramine—ABCB1—epilepsy syndrome	5.25e-06	0.00224	CrCbGaD
Orphenadrine—Promethazine—ABCB1—epilepsy syndrome	5.05e-06	0.00215	CrCbGaD
Orphenadrine—Tamoxifen—ABCB1—epilepsy syndrome	5.02e-06	0.00214	CrCbGaD
Orphenadrine—Doxepin—ABCB1—epilepsy syndrome	5e-06	0.00213	CrCbGaD
Orphenadrine—Methadone—ABCB1—epilepsy syndrome	4.97e-06	0.00212	CrCbGaD
Orphenadrine—Amitriptyline—ALB—epilepsy syndrome	4.05e-06	0.00173	CrCbGaD
Orphenadrine—Imipramine—ABCB1—epilepsy syndrome	3.89e-06	0.00166	CrCbGaD
Orphenadrine—Amitriptyline—ABCB1—epilepsy syndrome	3.87e-06	0.00165	CrCbGaD
Orphenadrine—CHRM2—GPCR downstream signaling—CDC42—epilepsy syndrome	1.73e-06	2.72e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—GAL—epilepsy syndrome	1.73e-06	2.72e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—GFAP—epilepsy syndrome	1.73e-06	2.72e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—AKT3—epilepsy syndrome	1.72e-06	2.71e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CHRM3—epilepsy syndrome	1.71e-06	2.69e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CASP2—epilepsy syndrome	1.71e-06	2.69e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—GRM5—epilepsy syndrome	1.71e-06	2.69e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—AVP—epilepsy syndrome	1.7e-06	2.68e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—AVP—epilepsy syndrome	1.68e-06	2.63e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CX3CR1—epilepsy syndrome	1.67e-06	2.62e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.66e-06	2.6e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.66e-06	2.6e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.65e-06	2.59e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CX3CR1—epilepsy syndrome	1.64e-06	2.58e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—BDKRB1—epilepsy syndrome	1.64e-06	2.57e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CHRM2—epilepsy syndrome	1.64e-06	2.57e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CX3CL1—epilepsy syndrome	1.64e-06	2.57e-05	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—AKT1—epilepsy syndrome	1.63e-06	2.55e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CX3CL1—epilepsy syndrome	1.61e-06	2.53e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—BDKRB1—epilepsy syndrome	1.61e-06	2.53e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CDC42—epilepsy syndrome	1.6e-06	2.51e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—GABBR1—epilepsy syndrome	1.59e-06	2.5e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CDC42—epilepsy syndrome	1.57e-06	2.47e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—GABBR1—epilepsy syndrome	1.57e-06	2.46e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.56e-06	2.44e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—AVP—epilepsy syndrome	1.55e-06	2.43e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HRH3—epilepsy syndrome	1.53e-06	2.4e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—AVP—epilepsy syndrome	1.52e-06	2.39e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—OPRM1—epilepsy syndrome	1.5e-06	2.36e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HRH3—epilepsy syndrome	1.5e-06	2.36e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—OPRM1—epilepsy syndrome	1.48e-06	2.32e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.48e-06	2.32e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.48e-06	2.32e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.48e-06	2.32e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.48e-06	2.32e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.48e-06	2.32e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ABCG2—epilepsy syndrome	1.45e-06	2.28e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—CCR5—epilepsy syndrome	1.45e-06	2.28e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—CCR5—epilepsy syndrome	1.43e-06	2.24e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ABCG2—epilepsy syndrome	1.42e-06	2.23e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CCR3—epilepsy syndrome	1.42e-06	2.23e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.42e-06	2.23e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CYP2C19—epilepsy syndrome	1.41e-06	2.22e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CYP11A1—epilepsy syndrome	1.4e-06	2.21e-05	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—AKT1—epilepsy syndrome	1.4e-06	2.19e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CCR3—epilepsy syndrome	1.4e-06	2.19e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.4e-06	2.19e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CYP2C19—epilepsy syndrome	1.38e-06	2.17e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.38e-06	2.17e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NPY—epilepsy syndrome	1.38e-06	2.17e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CYP11A1—epilepsy syndrome	1.38e-06	2.16e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NPY—epilepsy syndrome	1.36e-06	2.14e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ATP2A2—epilepsy syndrome	1.36e-06	2.14e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.35e-06	2.12e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.35e-06	2.12e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.35e-06	2.12e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—AGT—epilepsy syndrome	1.35e-06	2.11e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—OXT—epilepsy syndrome	1.33e-06	2.1e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CRH—epilepsy syndrome	1.33e-06	2.1e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CCL3—epilepsy syndrome	1.33e-06	2.1e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CXCL2—epilepsy syndrome	1.33e-06	2.1e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HSPB1—epilepsy syndrome	1.33e-06	2.1e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—AGT—epilepsy syndrome	1.32e-06	2.08e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CCR5—epilepsy syndrome	1.32e-06	2.07e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CCL3—epilepsy syndrome	1.31e-06	2.06e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HSPB1—epilepsy syndrome	1.31e-06	2.06e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CXCL2—epilepsy syndrome	1.31e-06	2.06e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CRH—epilepsy syndrome	1.31e-06	2.06e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—OXT—epilepsy syndrome	1.31e-06	2.06e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	1.3e-06	2.04e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CCR5—epilepsy syndrome	1.3e-06	2.03e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.29e-06	2.02e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CYP2D6—epilepsy syndrome	1.27e-06	1.99e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—HTR2A—epilepsy syndrome	1.27e-06	1.99e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.25e-06	1.97e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.25e-06	1.97e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.24e-06	1.95e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CYP2D6—epilepsy syndrome	1.24e-06	1.95e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PTK2B—epilepsy syndrome	1.24e-06	1.95e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TSC1—epilepsy syndrome	1.24e-06	1.95e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.22e-06	1.92e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—AGT—epilepsy syndrome	1.22e-06	1.92e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TSC1—epilepsy syndrome	1.22e-06	1.92e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PTK2B—epilepsy syndrome	1.22e-06	1.92e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ADRA2A—epilepsy syndrome	1.21e-06	1.9e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NTRK2—epilepsy syndrome	1.21e-06	1.89e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SST—epilepsy syndrome	1.21e-06	1.89e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CCR2—epilepsy syndrome	1.21e-06	1.89e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—AGT—epilepsy syndrome	1.2e-06	1.89e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—BCHE—epilepsy syndrome	1.2e-06	1.89e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—DUSP6—epilepsy syndrome	1.2e-06	1.88e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NTRK2—epilepsy syndrome	1.19e-06	1.86e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SST—epilepsy syndrome	1.19e-06	1.86e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CCR2—epilepsy syndrome	1.19e-06	1.86e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ADRA2A—epilepsy syndrome	1.18e-06	1.86e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.18e-06	1.85e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.18e-06	1.85e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—BCHE—epilepsy syndrome	1.18e-06	1.85e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—DUSP6—epilepsy syndrome	1.18e-06	1.85e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PLAT—epilepsy syndrome	1.18e-06	1.85e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ADRA2A—epilepsy syndrome	1.16e-06	1.82e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PLAT—epilepsy syndrome	1.16e-06	1.82e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.15e-06	1.8e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—SLC2A1—epilepsy syndrome	1.15e-06	1.8e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CXCL12—epilepsy syndrome	1.13e-06	1.78e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.13e-06	1.78e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PLCB1—epilepsy syndrome	1.13e-06	1.78e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—POMC—epilepsy syndrome	1.13e-06	1.78e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—TH—epilepsy syndrome	1.13e-06	1.77e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.13e-06	1.77e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.12e-06	1.77e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—SLC2A1—epilepsy syndrome	1.12e-06	1.76e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.12e-06	1.76e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.12e-06	1.76e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—BDKRB2—epilepsy syndrome	1.12e-06	1.75e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CXCL12—epilepsy syndrome	1.12e-06	1.75e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—POMC—epilepsy syndrome	1.11e-06	1.75e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—JUNB—epilepsy syndrome	1.11e-06	1.75e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CNR1—epilepsy syndrome	1.11e-06	1.75e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PRKCB—epilepsy syndrome	1.11e-06	1.74e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PLCB1—epilepsy syndrome	1.11e-06	1.74e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PLCB1—epilepsy syndrome	1.11e-06	1.74e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—TH—epilepsy syndrome	1.11e-06	1.74e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—IL6ST—epilepsy syndrome	1.11e-06	1.74e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—JUNB—epilepsy syndrome	1.1e-06	1.72e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CNR1—epilepsy syndrome	1.1e-06	1.72e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PLCB1—epilepsy syndrome	1.09e-06	1.71e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HTR7—epilepsy syndrome	1.09e-06	1.71e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HTR7—epilepsy syndrome	1.07e-06	1.68e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.07e-06	1.68e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.07e-06	1.68e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HBEGF—epilepsy syndrome	1.05e-06	1.66e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.04e-06	1.64e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HBEGF—epilepsy syndrome	1.04e-06	1.63e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—AKT3—epilepsy syndrome	1.04e-06	1.63e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—POMC—epilepsy syndrome	1.03e-06	1.62e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.02e-06	1.61e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—AKT3—epilepsy syndrome	1.02e-06	1.6e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—POMC—epilepsy syndrome	1.01e-06	1.59e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ADAM10—epilepsy syndrome	1.01e-06	1.59e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CCL2—epilepsy syndrome	1.01e-06	1.58e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1e-06	1.58e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ADAM10—epilepsy syndrome	9.95e-07	1.56e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CCL2—epilepsy syndrome	9.9e-07	1.56e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	9.85e-07	1.55e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—S100B—epilepsy syndrome	9.56e-07	1.5e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SOCS3—epilepsy syndrome	9.47e-07	1.49e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CDC42—epilepsy syndrome	9.45e-07	1.48e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—HMOX1—epilepsy syndrome	9.43e-07	1.48e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—S100B—epilepsy syndrome	9.41e-07	1.48e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SOCS3—epilepsy syndrome	9.32e-07	1.46e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CAT—epilepsy syndrome	9.31e-07	1.46e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CDC42—epilepsy syndrome	9.29e-07	1.46e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—HMOX1—epilepsy syndrome	9.24e-07	1.45e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	9.21e-07	1.45e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—AVP—epilepsy syndrome	9.14e-07	1.44e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CAT—epilepsy syndrome	9.12e-07	1.43e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ABCB1—epilepsy syndrome	9.05e-07	1.42e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—AVP—epilepsy syndrome	9e-07	1.41e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—AQP1—epilepsy syndrome	8.94e-07	1.4e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ABCB1—epilepsy syndrome	8.87e-07	1.39e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HES1—epilepsy syndrome	8.65e-07	1.36e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HES1—epilepsy syndrome	8.51e-07	1.34e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GPX1—epilepsy syndrome	8.42e-07	1.32e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—FYN—epilepsy syndrome	8.41e-07	1.32e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—H2AFX—epilepsy syndrome	8.38e-07	1.32e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MEF2C—epilepsy syndrome	8.36e-07	1.31e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	8.27e-07	1.3e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	8.24e-07	1.29e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GPX1—epilepsy syndrome	8.24e-07	1.29e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	8.23e-07	1.29e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	8.09e-07	1.27e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	8.09e-07	1.27e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—YWHAZ—epilepsy syndrome	8.08e-07	1.27e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NGF—epilepsy syndrome	7.99e-07	1.26e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	7.95e-07	1.25e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	7.86e-07	1.24e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CCR5—epilepsy syndrome	7.78e-07	1.22e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	7.65e-07	1.2e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HTR2A—epilepsy syndrome	7.61e-07	1.19e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	7.49e-07	1.18e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—AGT—epilepsy syndrome	7.38e-07	1.16e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—APOE—epilepsy syndrome	7.23e-07	1.14e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—AGT—epilepsy syndrome	7.23e-07	1.14e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TSC2—epilepsy syndrome	7.23e-07	1.14e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—AGT—epilepsy syndrome	7.22e-07	1.13e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	7.11e-07	1.12e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	7.1e-07	1.12e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—APOE—epilepsy syndrome	7.08e-07	1.11e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—APOE—epilepsy syndrome	7.07e-07	1.11e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	6.96e-07	1.09e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—KDR—epilepsy syndrome	6.93e-07	1.09e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	6.82e-07	1.07e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	6.67e-07	1.05e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	6.64e-07	1.04e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	6.59e-07	1.04e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	6.56e-07	1.03e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	6.54e-07	1.03e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	6.42e-07	1.01e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	6.38e-07	1e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—POMC—epilepsy syndrome	6.21e-07	9.75e-06	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—POMC—epilepsy syndrome	6.08e-07	9.55e-06	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—POMC—epilepsy syndrome	6.08e-07	9.54e-06	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	5.98e-07	9.39e-06	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	5.95e-07	9.34e-06	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	5.85e-07	9.19e-06	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	5.76e-07	9.05e-06	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ALB—epilepsy syndrome	5.66e-07	8.89e-06	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ALB—epilepsy syndrome	5.55e-07	8.71e-06	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	5.49e-07	8.61e-06	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	5.46e-07	8.58e-06	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	5.37e-07	8.44e-06	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	5.29e-07	8.3e-06	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	5.21e-07	8.18e-06	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	5.15e-07	8.09e-06	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—TH—epilepsy syndrome	5.14e-07	8.06e-06	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—RELA—epilepsy syndrome	4.99e-07	7.83e-06	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PTGS2—epilepsy syndrome	4.95e-07	7.78e-06	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	4.91e-07	7.71e-06	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	4.89e-07	7.68e-06	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PTGS2—epilepsy syndrome	4.85e-07	7.62e-06	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	4.81e-07	7.56e-06	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	4.54e-07	7.13e-06	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	4.5e-07	7.07e-06	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	4.47e-07	7.02e-06	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	4.43e-07	6.95e-06	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—JUN—epilepsy syndrome	4.37e-07	6.86e-06	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	4.3e-07	6.75e-06	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	4.29e-07	6.73e-06	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	4.25e-07	6.68e-06	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CAT—epilepsy syndrome	4.23e-07	6.64e-06	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	4.18e-07	6.57e-06	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	4.12e-07	6.48e-06	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	4.11e-07	6.46e-06	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	4.06e-07	6.37e-06	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SRC—epilepsy syndrome	3.92e-07	6.16e-06	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	3.86e-07	6.06e-06	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	3.82e-07	6.01e-06	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	3.82e-07	6e-06	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	3.76e-07	5.9e-06	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—AGT—epilepsy syndrome	3.35e-07	5.27e-06	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—APOE—epilepsy syndrome	3.29e-07	5.16e-06	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—POMC—epilepsy syndrome	2.82e-07	4.43e-06	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ALB—epilepsy syndrome	2.57e-07	4.04e-06	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—AKT1—epilepsy syndrome	2.49e-07	3.91e-06	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—AKT1—epilepsy syndrome	2.44e-07	3.83e-06	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	2.44e-07	3.83e-06	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	2.4e-07	3.76e-06	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	2.25e-07	3.54e-06	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.13e-07	1.78e-06	CbGpPWpGaD
